RE: Probably a naive question but....19 May 2017 22:52
Fredd1e - I doubt a buyback is either likely, wise or advisable. The cash in the bank will be already be forward budgeted towards the clinical trials planned and the various stages of them in the next two years. If they started spending that money on buying their own shares a.) the market would not like it and be quite confused actually and b.) it would bring forward the next fundraising which the market would also not like.
So, nice thought, but naaaahh :)